Literature DB >> 19172413

Heterogeneity of pT3 colorectal carcinomas according to the depth of invasion.

Rita Bori1, István Sejben, Mihály Svébis, Kornél Vajda, László Markó, Gábor Pajkos, Gábor Cserni.   

Abstract

Colorectal carcinomas (CRCs) infiltrating through the muscularis propria layer without infiltration of adjacent structures, organs or the serosa-i.e. the pT3 tumors, compose the largest subset of large intestinal carcinomas treated by surgical resection. They are heterogeneous in terms of prognosis. CRCs treated by surgery in a period of 69 months were prospectively classified as pT3a tumors (invading to a maximum of 5 mm beyond the muscularis propria) and pT3b tumors (invading deeper). Their nodal status, incidence of vascular invasion and the presence or absence of distant metastases were analyzed in relation to the depth of invasion. Of the 593 CRCs primarily treated by surgery 429 were pT3 tumors. CRCs categorized as pT3a had significantly lower rates of nodal involvement (44% vs 75%), massive nodal involvement (pN2) (9% vs 39%), venous invasion (17% vs 30%) and distant metastasis (11% vs 28%) than pT3b tumors. Significant differences in these prognostic variables in pT3a and pT3b cancers were observed both for carcinomas of the colon and those of the rectum. Such differences were not obvious in further 66 ypT3 cases of rectal carcinoma receiving neoadjuvant treatment before surgery. Tumors in the pT3a category are associated with a better prognostic profile than pT3b tumors. This subdivision might be useful in both prognostication and treatment planning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172413     DOI: 10.1007/s12253-009-9149-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  13 in total

Review 1.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Lymph node retrieval after neoadjuvant radiotherapy for rectal adenocarcinoma.

Authors:  N Scott; C Thorne; D Jayne
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

3.  Population-based analyses of lymph node metastases in colorectal cancer.

Authors:  Rocco Ricciardi; Robert D Madoff; David A Rothenberger; Nancy N Baxter
Journal:  Clin Gastroenterol Hepatol       Date:  2006-09-18       Impact factor: 11.382

4.  Routine elastic staining assists detection of vascular invasion in colorectal cancer.

Authors:  M Abdulkader; K Abdulla; E Rakha; P Kaye
Journal:  Histopathology       Date:  2006-11       Impact factor: 5.087

5.  The prognostic inhomogeneity in pT3 rectal carcinomas.

Authors:  S Merkel; U Mansmann; M Siassi; T Papadopoulos; W Hohenberger; P Hermanek
Journal:  Int J Colorectal Dis       Date:  2001-09       Impact factor: 2.571

6.  Predictors of distant metastasis and mortality in patients with stage II colorectal cancer.

Authors:  John H Heinzerling; Thomas Anthony; Edward H Livingston; Sergio Huerta
Journal:  Am Surg       Date:  2007-03       Impact factor: 0.688

7.  Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer.

Authors:  S J Cawthorn; D V Parums; N M Gibbs; R P A'Hern; S M Caffarey; C I Broughton; C G Marks
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 8.  The staging of colorectal cancer: 2004 and beyond.

Authors:  Carolyn C Compton; Frederick L Greene
Journal:  CA Cancer J Clin       Date:  2004 Nov-Dec       Impact factor: 508.702

9.  Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: All T3 rectal cancers are not equal.

Authors:  Gavin C Harewood; K Shiva Kumar; Jonathan E Clain; Michael J Levy; Heidi Nelson
Journal:  J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 4.029

10.  Direct tumor invasion in colon cancer: correlation with tumor spread and survival.

Authors:  Siu Kin C Wong; Bin B Jalaludin; Christopher J A Henderson; Matthew J Morgan; Angela S Berthelsen; Michael M Issac; Andrew Kneebone
Journal:  Dis Colon Rectum       Date:  2008-06-13       Impact factor: 4.585

View more
  7 in total

1.  An international survey-based study on colorectal cancer pathology reporting-guidelines versus local practice.

Authors:  Maria Urbanowicz; Heike I Grabsch; Frederic Fiteni; Yan Liu; Carmela Caballero; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2018-09-26       Impact factor: 4.064

2.  Does the depth of mesorectal invasion have prognostic significance in patients with ypT3 lower rectal cancer treated with preoperative chemoradiotherapy?

Authors:  Atsushi Ogura; Takashi Akiyoshi; Noriko Yamamoto; Hiroshi Kawachi; Yuichi Ishikawa; Hisashi Noma; Masato Nagino; Yosuke Fukunaga; Masashi Ueno
Journal:  Int J Colorectal Dis       Date:  2016-11-26       Impact factor: 2.571

3.  Association between histological type of tumour growth and patient survival in t2-t3 lymph node-negative rectal cancer treated with sphincter-preserving total mesorectal excision.

Authors:  Bartlomiej Szynglarewicz; Rafal Matkowski; Agnieszka Halon; Aleksandra Lacko; Marcin Stepien; Jozef Forgacz; Marek Pudelko; Jan Kornafel
Journal:  Pathol Oncol Res       Date:  2009-09-15       Impact factor: 3.201

Review 4.  Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.

Authors:  A C Rogers; D C Winter; A Heeney; D Gibbons; A Lugli; G Puppa; K Sheahan
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

5.  Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer.

Authors:  Lorenzo Macchi; Quoc Riccardo Bao; Laura Albertoni; Matteo Fassan; Valentina Chiminazzo; Marco Scarpa; Gaya Spolverato; Salvatore Pucciarelli
Journal:  Int J Clin Oncol       Date:  2022-06-18       Impact factor: 3.850

6.  Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy.

Authors:  Yoshito Akagi; Kazuo Shirouzu; Shin Fujita; Hideki Ueno; Yasumasa Takii; Koji Komori; Masaaki Ito; Kenichi Sugihara
Journal:  Exp Ther Med       Date:  2012-12-14       Impact factor: 2.447

7.  Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer.

Authors:  Yoshito Akagi; Kazuo Shirouzu; Tetsushi Kinugasa
Journal:  J Surg Oncol       Date:  2013-08-23       Impact factor: 3.454

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.